145 related articles for article (PubMed ID: 37886358)
1. A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3.
Wei J; Pan Y; Shen Z; Shen L; Xu L; Yu W; Huang W
Front Med (Lausanne); 2023; 10():1182227. PubMed ID: 37886358
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening.
Yao C; Shen Z; Shen L; Kadier K; Zhao J; Guo Y; Xu L; Cao J; Dong X; Yang B
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895928
[TBL] [Abstract][Full Text] [Related]
3. Molecular Docking and Molecular Dynamics Simulation of New Potential JAK3 Inhibitors.
Zhong Q; Li D; Qin J; Guo L; Zhao K
Curr Comput Aided Drug Des; 2023 May; ():. PubMed ID: 37231719
[TBL] [Abstract][Full Text] [Related]
4. QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.
Faris A; Ibrahim IM; Alnajjar R; Hadni H; Bhat MA; Yaseen M; Chakraborty S; Alsakhen N; Shamkh IM; Mabood F; M Naglah A; Ullah I; Ziedan N; Elhallaoui M
J Biomol Struct Dyn; 2023 Dec; ():1-30. PubMed ID: 38059345
[TBL] [Abstract][Full Text] [Related]
5. Identification of Chinese Herbal Compounds with Potential as JAK3 Inhibitors.
Su D; Gao YQ; Deng YJ; Zhang HH; Wu YR; Hu Y; Mei QX
Evid Based Complement Alternat Med; 2019; 2019():4982062. PubMed ID: 31093295
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases.
Sanachai K; Mahalapbutr P; Hengphasatporn K; Shigeta Y; Seetaha S; Tabtimmai L; Langer T; Wolschann P; Kittikool T; Yotphan S; Choowongkomon K; Rungrotmongkol T
ACS Omega; 2022 Sep; 7(37):33548-33559. PubMed ID: 36157769
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
Kaur M; Silakari O
J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
[TBL] [Abstract][Full Text] [Related]
8. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
Front Chem; 2020; 8():167. PubMed ID: 32328476
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore and Virtual Screening of JAK3 inhibitors.
Rajeswari M; Santhi N; Bhuvaneswari V
Bioinformation; 2014; 10(3):157-63. PubMed ID: 24748756
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potential WEE1 inhibitors via hybrid virtual screening.
Jin T; Xu W; Chen R; Shen L; Gao J; Xu L; Chi X; Lin N; Zhou L; Shen Z; Zhang B
Front Pharmacol; 2023; 14():1298245. PubMed ID: 38143493
[TBL] [Abstract][Full Text] [Related]
11. Design of Rational JAK3 Inhibitors Based on the Parent Core Structure of 1,7-Dihydro-Dipyrrolo [2,3-b:3',2'-e] Pyridine.
Li Y; Meng D; Xie J; Li R; Wang Z; Li J; Mou L; Deng X; Deng P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628248
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.
Kaur M; Singh PK; Singh M; Bahadur R; Silakari O
Mol Divers; 2018 Feb; 22(1):95-112. PubMed ID: 29138965
[TBL] [Abstract][Full Text] [Related]
13. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
15.
Faris A; Cacciatore I; Ibrahim IM; Al Mughram MH; Hadni H; Tabti K; Elhallaoui M
J Biomol Struct Dyn; 2023 Oct; ():1-23. PubMed ID: 37861428
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation.
Tian X; Zhao Q; Chen X; Peng Z; Tan X; Wang Q; Chen L; Yang Y
Front Pharmacol; 2022; 13():817715. PubMed ID: 35264955
[No Abstract] [Full Text] [Related]
17. High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.
Faris A; Ibrahim IM; Hadni H; Elhallaoui M
J Biomol Struct Dyn; 2023 Aug; ():1-26. PubMed ID: 37539779
[TBL] [Abstract][Full Text] [Related]
18. NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3.
Kim BH; Jee JG; Yin CH; Sandoval C; Jayabose S; Kitamura D; Bach EA; Baeg GH
Mol Cancer; 2010 Feb; 9():36. PubMed ID: 20149240
[TBL] [Abstract][Full Text] [Related]
19. JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M.
Nishiya N; Sakamoto Y; Oku Y; Nonaka T; Uehara Y
World J Biol Chem; 2015 Nov; 6(4):409-18. PubMed ID: 26629323
[TBL] [Abstract][Full Text] [Related]
20. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
Kang KM; Lee I; Nam H; Kim YC
Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
